Search Results

Business

Dr. Marwan Sabbagh Joins the Cognoptix Scientific Advisory Board

Cognoptix, a groundbreaking diagnostic company for the early-stage detection of Alzheimer’s disease (AD), announces today that Marwan Noel Sabbagh, MD has joined Cognoptix’ Scientific Advisory Board.

August 10, 2021

·

4 min read

Business

Cognoptix Co-Founder Lee Goldstein, M.D., Ph.D. Joins Cognoptix Board of Directors and Scientific Advisory Board

Cognoptix, a leading healthcare company for early-stage detection of Alzheimer’s disease (AD), announces its co-founder, Lee Goldstein, M.D., Ph.D. has joined Cognoptix’s Scientific Advisory Board, serving as Co-Chair, and the company’s Board of Directors.

December 21, 2020

·

4 min read

Genetown

Cognoptix President & CEO, Susanne Wilke, PhD, MBA, to Present at Sachs 4th Annual Neuroscience Innovation Forum

Cognoptix, a leading medical device/diagnostics company dedicated to the early detection of Alzheimer’s disease (AD), announced today that Dr. Susanne Wilke , the Company’s President and Chief Executive Officer, will present a “Spotlight Showcase” of Cognoptix under the title “Early-Stage Detection of Alzheimer’s Disease

April 28, 2021

·

3 min read

Business

Cognoptix Announces Formation of a New Board of Directors

Cognoptix is a breakthrough diagnostics company developing an innovative office-based device-drug system for the early detection of Alzheimer’s disease (AD). As another milestone of the Series R restart, recapitalization, and revitalization, the company named a new Board of Directors (BOD) formed under the leadership of Dr. S

December 30, 2020

·

7 min read

Business

Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer, Mike Kaswan, MBA, To Management Team

Cognoptix, a leading diagnostics company dedicated to the early detection of Alzheimer’s disease (AD), announces two appointments to its senior management team. Dr. Carl H. Sadowsky, MD will serve as the company’s new Chief Medical Officer (CMO) and Mike Kaswan, MBA will be Cognoptix’s Chief Financial Officer (CFO).

January 4, 2021

·

3 min read

Genetown

Cognoptix CEO Dr. Susanne Wilke to Present at the 13th Annual BIOTECH SHOWCASE™ DIGITAL Event

Cognoptix, a privately-held, diagnostics company with a breakthrough technology for the early detection of Alzheimer’s disease, announces that the company will present at the 13th Annual Biotech Showcase™ Digital Event, January 11-15, 2021.

January 11, 2021

·

3 min read

Business

Cognoptix Announces New Scientific Advisory Board with Alzheimer’s Research Leaders

Cognoptix, a leading diagnostics company dedicated to early detection of Alzheimer’s disease (AD), announced today the formation of its new Scientific Advisory Board (SAB) with appointment of five world-class scientists and clinical researchers in AD. The SAB includes Jeffrey L. Cummings , MD, ScD; Lee E. Goldstein , MD, PhD

November 18, 2020

·

5 min read

Business

Cognoptix Revitalizes, Appoints New Chief Executive Officer Dr. Susanne Wilke, PhD, Raises Oversubscribed $2.6m Series R

Cognoptix, a healthcare company developing the Sapphire II System, a breakthrough technology for early detection of Alzheimer’s disease (AD), announces the closing of an over-subscribed Series R financing round. Cognoptix has undergone a complete revitalization over the past year. The company attracted the involvement of

September 28, 2020

·

3 min read

Business

Cognoptix Expands Clinical Advisory Board

December 4, 2014

·

1 min read

Business

Cognoptix Expands Clinical Advisory Board

December 3, 2014

·

3 min read